comparemela.com

Latest Breaking News On - Linkedin juvena - Page 1 : comparemela.com

Juvena Therapeutics Receives FDA Orphan Drug Designation for JUV-161 for the Treatment of Myotonic Dystrophy Type 1

REDWOOD CITY, Calif. (BUSINESS WIRE) Jan 23, 2024

United statesTanya stevensonLinkedin juvenaShira derasmoJeremy oconnellHanadie yousefOffice of orphan products developmentCuttlefish communicationsMyotonic dystrophy foundationDrug administrationOrphan drugMyotonic dystrophy typeMyotonic dystrophyJuvena therapeuticsJeremyo connellChief scientific officer

Slone Partners Places Gayarthri Swaminath as SVP of Discovery and Edward Moler as VP of Data Science at Juvena Therapeutics

South Riding, VA (PRWEB) February 08, 2023 Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies,

Andhra pradeshUnited statesGreenfire bioLinkedin juvenaEdward molerHanadie yousefGayathri swaminathEddie molerTara kochisTexasam universityCornell universityUniversity of hyderabadUs department of energyQuest diagnosticsStanford universityGe healthcare

Slone Partners Places Gayathri Swaminath as SVP of Discovery and Edward Moler as VP of Data Science at Juvena Therapeutics

South Riding, VA (PRWEB) February 08, 2023 Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies,

Andhra pradeshUnited statesGreenfire bioLinkedin juvenaEdward molerHanadie yousefGayathri swaminathEddie molerTara kochisTexasam universityCornell universityUniversity of hyderabadUs department of energyQuest diagnosticsStanford universityGe healthcare

vimarsana © 2020. All Rights Reserved.